Effect of Hypoxia-inducible Factor-1α Silencing on the Sensitivity of Human Brain Glioma Cells to Doxorubicin and Etoposide (original) (raw)

Abstract

Multidrug resistance (MDR) is a significant problem underlying the poor prognosis associated with gliomas. Hypoxia-inducible factor-1α (HIF-1α) is thought to induce the genes expression involved in MDR. To evaluate the effect of silencing HIF-1α in human glioma T98G cells, cells were transfected with HIF-1α-small interference RNA (HIF-1α-siRNA) and cultured under hypoxic conditions. The effect of HIF-1α-siRNA on HIF-1α and multidrug resistance-associated protein 1 gene (MRP1) and protein levels was determined. Silencing rates of HIF-1α were 90%, 85%, and 88% at 24, 48, 72 h post-transfection, respectively. Corresponding rates of HIF-1α protein were 74.5%, 61.1% and 59.1%. MRP1 protein levels decreased by 7.6%, 36.8% and 45.2%. HIF-1α-siRNA transfected cells were significantly more sensitive to doxorubicin and etoposide compared to non-transfected cells. These findings suggest that the HIF-1α plays a role in mediating chemotherapeutic drug resistance in glioma cells. HIF-1α silencing may prove to be an effective therapeutic means of treating gliomas.

Access this article

Log in via an institution

Subscribe and save

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Yamanaka R (2008) Cell- and peptide-based immunotherapeutic approaches for glioma. Trends Mol Med 14:228–235
    Article PubMed CAS Google Scholar
  2. National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology (2008) Central Nervous System Cancers V.1
  3. DeAngelis LM (2001) Brain tumors. N Engl J Med 344:114–123
    Article PubMed CAS Google Scholar
  4. Davis FG, Kupelian V, Freels S et al (2001) Prevalence estimates for primary brain tumors in the United States by behavior and major histology groups. NeuroOncol 3:152–158
    CAS Google Scholar
  5. Curran WJ Jr, Scott CB, Horton J et al (1993) Recursive partitioning analysis of prognostic factors in three radiation therapy oncology group malignant glioma trials. J Natl Cancer Inst 85:704–710
    Article PubMed Google Scholar
  6. Song X, Liu X, Chi W et al (2006) Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF-1alpha gene. Cancer Chemother Pharmacol 58:776–784
    Article PubMed CAS Google Scholar
  7. Comerford KM, Wallace TJ, Karhausen J et al (2002) Hypoxia-inducible factor-1- dependent regulation of the multidrug resistance (MDR1) gene. Cancer Res 62:3387–3394
    PubMed CAS Google Scholar
  8. Goldman B (2003) Multidrug resistance: can new drugs help chemotherapy score against cancer? J Natl Cancer Inst 95:255–257
    Article PubMed Google Scholar
  9. Mattern J (2003) Drug resistance in cancer: a multifactorial problem. Anticancer Res 23:1769–1772
    PubMed Google Scholar
  10. Fardel O, Lecureur V, Guillouzo A (1996) The P-glycoprotein multidrug transporter. Gen Pharmacol 27:1283–1291
    PubMed CAS Google Scholar
  11. Cole SP, Bhardwaj G, Gerlach JH et al (1992) Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 258:1650–1654
    Article PubMed CAS Google Scholar
  12. Decleves X, Fajac A, Lehmann-Che J et al (2002) Molecular and functional MDR1-Pgp and MRPs expression in human glioblastoma multiforme cell lines. Int J Cancer 98:173–180
    Article PubMed CAS Google Scholar
  13. Mohri M, Nitta H, Yamashita J (2000) Expression of multidrug resistance- associated protein (MRP) in human gliomas. J Neurooncol 49:105–115
    Article PubMed CAS Google Scholar
  14. Zhu H, Chen XP, Luo SF et al (2005) Involvement of hypoxia-inducible factor-1-alpha in multidrug resistance induced by hypoxia in HepG2 cells. J Exp Clin Cancer Res 24:565–574
    PubMed CAS Google Scholar
  15. Kizaka-Kondoh S, Inoue M, Harada H et al (2003) Tumor hypoxia: a target for selective cancer therapy. Cancer Sci 94:1021–1028
    Article PubMed CAS Google Scholar
  16. Han HK, Han CY, Cheon EP et al (2007) Role of hypoxia-inducible factor-alpha in hepatitis-B-virus X protein-mediated MDR1 activation. Biochem Biophys Res Commun 357:567–573
    Article PubMed CAS Google Scholar
  17. Vezmar M, Georges E (2000) Reversal of MRP-mediated doxorubicin resistance with quinoline-based drugs. Biochem Pharmacol 59:1245–1252
    Article PubMed CAS Google Scholar
  18. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 25:402–408
    Article PubMed CAS Google Scholar
  19. Yu JY, DeRuiter SL, Turner DL (2002) RNA interference by expression of short- interfering RNAs and hairpin RNAs in mammalian cells. Proc Natl Acad Sci USA 99:6047–6052
    Article PubMed CAS Google Scholar
  20. Brummelkamp TR, Bernards R, Agami R (2002) A system for stable expression of short interfering RNAs in mammalian cells. Science 296:550–553
    Article PubMed CAS Google Scholar
  21. Lee NS, Dohjima T, Bauer G et al (2002) Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells. Nat Biotechnol 20:500–505
    PubMed CAS Google Scholar
  22. Miyagishi M, Taira K (2002) U6 promoter-driven siRNAs with four uridine 3′ overhangs efficiently suppress targeted gene expression in mammalian cells. Nat Biotechnol 20:497–500
    Article PubMed CAS Google Scholar
  23. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T (2001) Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411:494–498
    Article PubMed CAS Google Scholar

Download references

Acknowledgments

This study was supported by the Country Natural Science Fund and West China Hospital.

Author information

Authors and Affiliations

  1. Department of Neurology, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, People’s Republic of China
    Lei Chen & Dong Zhou
  2. Department of Gastroenterology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, 610075, People’s Republic of China
    Peimin Feng
  3. Key Laboratory of Transplant Engineering and Immunology, Ministry of Health, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, People’s Republic of China
    Shengfu Li, Dan Long, Jingqiu Cheng & Yanrong Lu

Authors

  1. Lei Chen
    You can also search for this author inPubMed Google Scholar
  2. Peimin Feng
    You can also search for this author inPubMed Google Scholar
  3. Shengfu Li
    You can also search for this author inPubMed Google Scholar
  4. Dan Long
    You can also search for this author inPubMed Google Scholar
  5. Jingqiu Cheng
    You can also search for this author inPubMed Google Scholar
  6. Yanrong Lu
    You can also search for this author inPubMed Google Scholar
  7. Dong Zhou
    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence toDong Zhou.

Rights and permissions

About this article

Cite this article

Chen, L., Feng, P., Li, S. et al. Effect of Hypoxia-inducible Factor-1α Silencing on the Sensitivity of Human Brain Glioma Cells to Doxorubicin and Etoposide.Neurochem Res 34, 984–990 (2009). https://doi.org/10.1007/s11064-008-9864-9

Download citation

Keywords